Malcolm Clarke

Malcolm Clarke

Ondokuz Mayis Üniversitesi

H-index: 28

Asia-Turkey

About Malcolm Clarke

Malcolm Clarke, With an exceptional h-index of 28 and a recent h-index of 18 (since 2020), a distinguished researcher at Ondokuz Mayis Üniversitesi, specializes in the field of Telemedicine, telehealth, ambient assisted living.

His recent articles reflect a diverse array of research interests and contributions to the field:

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised …

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open …

Digital identity network interface system

An Assessment of the Potential Benefits of Video Consultation in the Emergency Department: Mixed Methods Study

A Patient Technology Acceptance Model (PTAM) for Adoption of Telehealth

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Malcolm Clarke Information

University

Position

Professor

Citations(all)

4475

Citations(since 2020)

3056

Cited By

1729

hIndex(all)

28

hIndex(since 2020)

18

i10Index(all)

57

i10Index(since 2020)

26

Email

University Profile Page

Ondokuz Mayis Üniversitesi

Google Scholar

View Google Scholar Profile

Malcolm Clarke Skills & Research Interests

Telemedicine

telehealth

ambient assisted living

Top articles of Malcolm Clarke

Title

Journal

Author(s)

Publication Date

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised …

The Lancet Child & Adolescent Health

Saul N Faust

Richard Haynes

Christine E Jones

Natalie Staplin

Elizabeth Whittaker

...

2024/3/1

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Nature Communications

Peter Sandercock

Janet Darbyshire

David DeMets

Robert Fowler

David Lalloo

...

2024/1/31

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

The Lancet Diabetes & Endocrinology

O Abani

A Abbas

F Abbas

J Abbas

K Abbas

...

2023/12/1

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open …

The Lancet

Obbina Abani

Ali Abbas

Fatima Abbas

Joshua Abbas

Kasim Abbas

...

2023/5/6

Digital identity network interface system

2023/2/28

An Assessment of the Potential Benefits of Video Consultation in the Emergency Department: Mixed Methods Study

Interactive Journal of Medical Research

Jane Turner

Malcolm Clarke

Grizelda George

Russell Wynn Jones

Rick Pullinger

...

2022/9/15

A Patient Technology Acceptance Model (PTAM) for Adoption of Telehealth

Digital Medicine and Healthcare Technology

Precious Onyeachu

Malcolm Clarke

2022/3/28

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Medrxiv

RECOVERY Collaborative Group

Peter W Horby

Marion Mafham

Leon Peto

Mark Campbell

...

2021/6/16

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Lancet (London, England)

RECOVERY Collaborative Group

2022/1/1

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

The Lancet

Obbina Abani

Ali Abbas

Fatima Abbas

Mustafa Abbas

Sadia Abbasi

...

2021/5/1

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Lancet (London, England)

RECOVERY Collaborative Group

2021/2/13

Results from Telehealth

Smart and Pervasive Healthcare

Malcolm Clarke

2021/12/3

Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial

Jama

Hesham Abdelhady

Marwa Abdelrazik

Zakee Abdi

David Abdo

Amina Abdulle

...

2021/11/2

The Successful Usage of the DICOM Images Exchange System (ePACS) in the Czech Republic

Applied Clinical Informatics

Jan Bruthans

2020/1

See List of Professors in Malcolm Clarke University(Ondokuz Mayis Üniversitesi)

Co-Authors

H-index: 33
Jasni Mohamad Zain

Jasni Mohamad Zain

Universiti Teknologi MARA

H-index: 11
Hülya Gökalp

Hülya Gökalp

Ondokuz Mayis Üniversitesi

H-index: 4
Brian Ondiege

Brian Ondiege

Brunel University London

academic-engine